Knura M, Garczorz W, Borek A, Drzymaa F, Rachwa K, George K, et al
Research-Grade LC216 from Empower Peptides Each LC216 (LIPO-C) vial contains 20 mg/mL of actives in a 10 mL sterile aqueous solution
In 2024, Novo Nordisk reported a total revenue of $40.66 billion, of which $20.88 billion was attributed to its GLP-1 drugs, which accounted for 51.4% of total revenues
Wegovy significantly reduced the risk of major adverse cardiovascular events (cardiovascular death, heart attack, and stroke), which occurred in 6.5% of participants who received Wegovy compared to 8% of participants who received a placebo
International Journal of Molecular Sciences, 25 (7), 3797
This multi-faceted treatment also gives people the knowledge to achieve their weight goals